THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

Aperio Group, LLC's Holding History (CIK: 0001364615)

Note: Option positions (PUT/CALL) are excluded.

Q4 2020
Shares 12,235 Value ($000) $218 Avg Close $17.95 Range $14.48 - $20.53
Q3 2020
Shares 13,731 Value ($000) $203 Avg Close $18.73 Range $14.62 - $22.82
Q2 2020
Shares 16,568 Value ($000) $348 Avg Close $25.69 Range $20.17 - $31.35
Q1 2020
Shares 18,501 Value ($000) $428 Avg Close $25.03 Range $16.86 - $31.54
Q4 2019
Shares 15,763 Value ($000) $408 Avg Close $19.43 Range $15.72 - $26.47
Q3 2019
Shares 17,637 Value ($000) $343 Avg Close $20.20 Range $16.00 - $24.34
Q2 2019
Shares 10,932 Value ($000) $178 Avg Close $20.26 Range $15.18 - $25.38
Q1 2019
Shares 12,064 Value ($000) $274 Avg Close $25.36 Range $21.04 - $28.63
Q4 2018
Shares 8,412 Value ($000) $215 Avg Close $27.00 Range $21.70 - $35.48
Q3 2018
Shares 6,157 Value ($000) $201 Avg Close $27.25 Range $22.26 - $32.79
Q2 2017
Shares 5,144 Value ($000) $205 Avg Close $38.45 Range $34.85 - $43.44